A good breakout in a sector which is tracing back to covid level

Pembelian

LINCOLN PHARMA LTD (NSE:LINCOLN)

Diupdate

NSE:LINCOLN LINCOLN PHARMA LTD

Solid technical setup and pharma seems to be on upside especially post Q2. Volume is really good but RSI is 71. so possibility of retesting breakout levels. Short term sl should be aroun 309. Positional players can hold with weekly closing basis 298 sl

Komentar:

RSI continues to be a problem as consolidation continues. Stock entering BB now post BB expansion. interesting day tomorrow as its weekly closing

Trade aktif:

Solid weekly closing. consolidation, move, consolidation , move. Doesnt come under volume scanners easily. smart movement happening.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.